Title: CLINICAL EVALUATION OF CB 1348 IN LEUKEMIAS AND LYMPHOMAS
Abstract: Annals of the New York Academy of SciencesVolume 68, Issue 3 p. 979-995 CLINICAL EVALUATION OF CB 1348 IN LEUKEMIAS AND LYMPHOMAS Charles A. Doan, Charles A. Doan College of Medicine, Ohio Stale University, Colzcmbus, OhioSearch for more papers by this authorBruce K. Wiseman, Bruce K. Wiseman College of Medicine, Ohio Stale University, Colzcmbus, OhioSearch for more papers by this authorBertha A. Bouroncle, Bertha A. Bouroncle College of Medicine, Ohio Stale University, Colzcmbus, OhioSearch for more papers by this author Charles A. Doan, Charles A. Doan College of Medicine, Ohio Stale University, Colzcmbus, OhioSearch for more papers by this authorBruce K. Wiseman, Bruce K. Wiseman College of Medicine, Ohio Stale University, Colzcmbus, OhioSearch for more papers by this authorBertha A. Bouroncle, Bertha A. Bouroncle College of Medicine, Ohio Stale University, Colzcmbus, OhioSearch for more papers by this author First published: April 1958 https://doi.org/10.1111/j.1749-6632.1958.tb42654.xCitations: 23 The investigation on which this paper is based was supported by a grant from the Dorothy H. and Lewis Rosenstiel Foundation, New York, N. Y. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Haddow, A. 1954. Experimental and clinical aspects of the action of various carboxylic acid derivatives in the aromatic nitrogen mustard series. In Ciba Foundation Symposium on Leukemia Research.: 196. G. E. W. Wolstenholme & M. P. Cameron, Eds. Little, Brown. Boston , Mass . 2 Bollag, W. 1953. Experimental investigations of the effect of cytostatic substances in the blood picture. Schweiz. med. Wochschr. 83: 1027. 3 Galton, D. A. G., L. S. Israels, J. D. N. Navarro & M. Till. 1955. Clinical trials of p-(di-2-chloroethylamino)-phenylbutyric acid (CB 1348) in malignant lymphoma. Brit. Med. J. 2: 1172. 4 Bouroncle, B. A., C. A. Doan, B. K. Wiseman & W. J. Frajola. 1956. Evaluation of CB 1348 in Hodgkin's disease and allied disorders. A.M.A. Arch. Internal Med. 97: 703. 5 Altman, S. J., A. Haut, G. E. Cartwright & M. M. Wintrobe. 1956. Early experience with p-(N1N-di-2-chloroethyl) aminophenylbutyric acid (CB 1348), a new chemotherapeutic agent effective in the treatment of chronic lymphocytic leukemia. Cancer. 9: 512. 6 Ultmann, J. E., G. A. Hyman & A. Gellhorn. 1956. Chlorambucil in treatment of chronic lymphocytic leukemia and certain lymphomas. J. Am. Med. Assoc. 162: 178. 7 Shanbrom, E., A. G. Knudson & S. Rappaport. 1957. Clinical evaluation of chlorambucil. (Abstr.) Clin. Research Proc. 5: 31. 8 Hall, B. E., F. M. Willet, T. V. Feichtmeir, D. R. Hales, R. W. Jerner & J. Franco. 1957. Clinical evaluation of chlorambucil in the treatment of human neoplastic disease. (Abstr.) Clin. Research Proc. 5: 83. 9 Paterson, E. & P. B. Kunkler. 1953. Triethylene melamine in human malignant disease. Brit. Med. J. 1: 59. 10 Hamermon, D. J. & S. Malamed. 1953. Some clinical experience in the use of triethylene melamine (TEM). J. Mt. Sinai Hosp. N. Y. 20: 16. 11 Burtner, C. W., L. C. Jensen & J. M. Rumball. 1955. Triethylene melamine in the treatment of lymphomas and other neoplastic diseases. Ann. Internal Med. 38: 1272. 12 Slipyan, A. 1953. Unusual toxicity to triethylene melamine in a case of chronic myelogenous leukemia. Ann. Internal Med. 38: 331. 13 Jacobson, L. O., C. L. Spurr, E. S. G. Barron, T. Smith, C. Lushbaugh & G. F. Dick. 1946. Studies on the effect of methyl-bis (β-chloroethyl) amine hydrochloride on neoplastic diseases and allied disorders of the hemopoietic system. J. Am. Med. Assoc. 132: 263. 14 Zanes, R. P., C. A. Doan & H. A. Hoster. 1948. Studies in Hodgkin's syndrome. VII. Nitrogen mustard therapy. J. Lab. Clin. Med. 33: 1002. 15 Goodman, L. S., M. M. Wintrobe, W. Dameshek, M. J. Goodman, A. Gilman & M. T. McLennan. 1946. Nitrogen mustard therapy: use of methyl-bis (β-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. J. Am. Med. Assoc. 132: 126. 16 Doan, C. A., B. K. Wiseman, C. S. Wright, J. H. Geyer, W. Myers & J. W. Myers. 1947. Radioactive phosphorus P32: a six year clinical evaluation of internal radiation therapy. J. Lab. Clin. Med. 32: 943. Citing Literature Volume68, Issue3Comparative Clinical and Biological Effects of Alkylating AgentsApril 1958Pages 979-995 ReferencesRelatedInformation
Publication Year: 1958
Publication Date: 1958-04-01
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 35
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot